IntelGenx Technologies Corp.
IGX
株式のランク
#28144
IntelGenx Technologies Corp. is a pharmaceutical drug delivery enterprise... IntelGenx Technologies Corp. is a pharmaceutical drug delivery enterprise focused on the creation and manufacturing of advanced oral thin film products. The company's diverse product pipeline encompasses various oral film formulations designed to address a wide spectrum of medical conditions. These include INT0008/2008, a Rizatriptan film for migraine management; INT0046/2018 for adult applications; INT0007/2006, an oral film targeting erectile dysfunction; INT0043/2015, a montelukast-based film for Alzheimer's disease; INT0027/2011, intended for opioid addiction treatment; INT0010/2006, addressing neuropathic pain and nausea in cancer patients undergoing chemotherapy; INT0036/2013, formulated for schizophrenia or bipolar I disorder; and INT0048/2020, developed for veterinary health. Additionally, IntelGenx is actively developing other candidates identified as INT0039/2013, INT0040/2014, INT0052/2020, INT0053/2020, and INT0054/2020. The company has established strategic partnerships, including a comprehensive licensing, development, and supply agreement with Tilray, Inc., alongside a development pact with Cynapsus Therapeutics Inc. Founded in 2003, IntelGenx Technologies Corp. is headquartered in Montreal, Canada.
株価
$0.17446996
最終同期: 2024-06-11
時価総額
$26.97M
変化（1日）
-0.57%
変化（1年）
2.63%
国
CA
取引 IntelGenx Technologies Corp. (IGX)
カテゴリー
Healthcare
IntelGenx Technologies Corp.（IGX）の営業利益率
October 2026 時点の営業利益率 TTM: -913.47%
IntelGenx Technologies Corp. の最新の財務報告と株価によると、現在の営業利益率（TTM）は -913.47% です。2022 年末時点では -990.84% でした。
IntelGenx Technologies Corp. の営業利益率の履歴（2003 から 2026）
各年末の営業利益率
| 年 | 営業利益率 | 変化 |
|---|---|---|
| 2026 (TTM) | -913.47% | 0.00% |
| 2023 | -913.47% | -7.81% |
| 2022 | -990.84% | 90.55% |
| 2021 | -520.00% | 28.17% |
| 2020 | -405.70% | -68.48% |
| 2019 | -1,287.06% | 160.90% |
| 2018 | -493.31% | 927.94% |
| 2017 | -47.99% | 155.40% |
| 2016 | -18.79% | -169.08% |
| 2015 | 27.20% | -125.35% |
| 2014 | -107.29% | -37.94% |
| 2013 | -172.89% | -5.33% |
| 2012 | -182.62% | -67.15% |
| 2011 | -555.91% | 147.59% |
| 2010 | -224.53% | 123.19% |
| 2009 | -100.60% | -55.18% |
| 2008 | -224.43% | 156.96% |
| 2007 | -87.34% | -69.72% |
| 2006 | -288.46% | 0.00% |
| 2005 | 0.00% | 0.00% |
| 2004 | 0.00% | 0.00% |
| 2003 | 0.00% | 0.00% |
同業他社の営業利益率
| 企業 | 営業利益率 | 営業利益率の差 | 国 |
|---|---|---|---|
| 38.59% | -100.04% |
US
|
|
| -149.01% | -99.84% |
US
|
|
| 25.57% | -100.03% |
AU
|
|
| 0.00% | - |
CH
|
|
| 28.81% | -100.03% |
NL
|
企業の営業利益率とは？
営業利益率は、企業の収益性を評価するための重要な指標です。高い営業利益率は一般的に良いとされており、企業が製品やサービスをその生産コストよりもはるかに高く販売できていることを示します。営業利益率は、企業の利益を売上高で割ることで計算されます。